Quantcast

EUCODIS Bioscience and Martin-Luther-University Halle, Germany, to Collaborate in the Characterization of Industrial Enzymes

April 27, 2010

VIENNA, Austria, April 27, 2010 /PRNewswire/ — EUCODIS Bioscience, a
developer and manufacturer of customized enzymes, and
Martin-Luther-University Halle-Wittenberg, Germany, (MLU), today announced a
collaboration agreement for the characterization of novel lipases,
phospholipases, and other enzymes that EUCODIS Bioscience is marketing or has
under development.

“Given the breadth of potential uses of our enzymes, we would like to
provide our customers with comprehensive analytical data on the
characteristics of each enzyme in a corresponding range of environments”,
said Thomas Fischer, CEO of EUCODIS Bioscience, commenting on the
collaboration.

“We are extremely pleased that the collaboration with MLU gives us access
to the extensive scientific experience and state-of-the-art instrumentation
in enzyme research and protein analysis that Professor Bordusa and his team
have built at the Institute of Biochemistry and Biotechnology. The Institute
will serve as a ‘center of excellence” for the extensive characterization of
our enzymes, and the data generated will be of substantial value to our
customers in the short term.”

“We are excited about the opportunity to collaborate with EUCODIS
Bioscience as an industry partner”, said Prof. Frank Bordusa, Head of the
Department Natural Materials Biochemistry of the Institute of Biochemistry
and Biotechnology, Martin-Luther-University Halle-Wittenberg, Germany.
“Lipases are the most versatile class of commercial enzymes. A thorough
characterization of these enzyme in relation to a diverse range of potential
substrates and processes is important to industrial users, and scientifically
challenging. Our collaboration with an industrial enzyme developer also has
the potential to generate further projects of commercial value.”

Industrial enzymes are used in extremely diverse applications. Lipases
are part of the formulations of laundry detergents, moisturizing cosmetics,
bakery mixes, or animal feeds, and enable industrial processes such as the
extraction and processing of vegetable oils, or the production of fine
chemicals from biomass in a biorefinery, among many other applications.

About MLU’s Institute of Biochemistry and Biotechnology

The Institute of Biochemistry and Biotechnology of the
Martin-Luther-University Halle-Wittenberg is one of the most successful
institutes of the university in terms of the recruitment of third-party
funds. Currently, research covered by third-party funds includes several
Collaborative and Interdisciplinary Research Centers, DFG research groups and
activities within several DFG Priority Programs, as well as the
application-oriented ProNet-T3 network, which has recently been funded with
EUR 11 million by the German Ministry of Science and Education.

The Department of Natural Materials Biochemistry is involved in a number
of the aforementioned activities and has long-term experience in the use of
hydrolases as biocatalysts for chemical applications. The main field of
interest covers the optimization of these enzymes by rational and
evolutionary protein engineering including the identification of new enzymes
for semisynthesis.

For details on MLU’s Institute of Biochemistry and Biotechnology please
visit http://www.biochemtech.uni-halle.de/

About EUCODIS Bioscience

EUCODIS Bioscience develops and customizes enzymes for the chemical,
health care, and other industries.

Customers use EUCODIS Bioscience’ enzymes to make their manufacturing
processes more efficient and cleaner, and to introduce products with superior
properties. The Company’s technology of in vivo-recombination is a proven
tool for the development of enzymes that perform to customers’ specific
requirements.

Enzymes are biological catalysts. They are at the center of industrial,
or “white” biotechnology, a fast growing industry segment with sales in
excess of EUR100 billion.

Led by an experienced management team, EUCODIS Bioscience is backed by
Austrian and German institutional venture capital funds, founders, and
private investors. The Company is headquartered in Austria, Europe, with a
subsidiary in Germany.

    For more information, please visit http://www.eucodisbioscience.com

    Company contact EUCODIS Bioscience:
    Thomas Fischer, MBA
    CEO
    EUCODIS Bioscience
    Campus Vienna Biocenter II
    Viehmarktgasse 2 a/ 2 OG
    A-1030 Vienna
    AUSTRIA
    +43-1-8900804
    office@eucodisbioscience.com

    Media contact EUCODIS Bioscience:
    Frank Butschbacher
    Investor Relations & Communications

http://www.butschbacher.net

    +43-650-7844940
    office@butschbacher.net

SOURCE EUCODIS Bioscience


Source: newswire



comments powered by Disqus